Clinical Trial Update: Regeneration of Human Intrabony Defects With rhFGF-2/HA [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating regeneration of intrabony defects in periodontitis using recombinant human fibroblast growth factor-2 with hydro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• rhFGF-2/HA (recombinant human fibroblast growth factor-2 with hydroxyapatite)

Snippet

Sponsor: Universidade Federal Fluminense | Conditions: Periodontitis | Phase 1, Phase 2 | Status: COMPLETED